Arbor Biotechnologies to Present Data Supporting Therapeutic Programs in PH1 and ALS, and the Discovery of a Novel Type V Nuclease at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
GlobeNewswire
- Oral and poster presentations showcase data demonstrating pipeline progress and continued advancement of Arbor’s pipeline..